ASM STRATCONSULT LLP

Pharma MachTech & LabNext Expo 2026: A Landmark Moment for ASM

Reflecting on ASM StratConsult LLP's role as Knowledge Partner to EEPC India, the White Paper on India's Pharmaceutical Machinery Manufacturing Industry, and its launch by Shri Piyush Goyal alongside Sandip Mukherjee, CEO, ASM StratConsult LLP.

Shri Piyush Goyal alongside Sandip Mukherjee during the launch of the White Paper
Shri Piyush Goyal alongside Sandip Mukherjee, CEO, ASM StratConsult LLP, during the White Paper launch.

Some moments in an organisation's journey go beyond an event, a partnership or a professional milestone. For ASM StratConsult LLP, Pharma MachTech & LabNext Expo 2026 was one such occasion — bringing together research, industry dialogue and a national platform for the pharmaceutical machinery ecosystem.

A Significant Industry Platform

Held from 7–9 September 2026 at Bharat Mandapam, New Delhi, Pharma MachTech & LabNext Expo 2026 brought together manufacturers, technology providers, buyers, policymakers, industry leaders and other stakeholders connected with the pharmaceutical machinery and laboratory ecosystem.

For ASM, the Expo represented more than an exhibition. It provided an opportunity to contribute knowledge and strategic insight to an industry that is becoming increasingly important to India's manufacturing, innovation and export ambitions.

“Better business decisions begin with better industry intelligence.”

The thinking behind ASM's knowledge-led approach

ASM as Knowledge Partner to EEPC India

ASM StratConsult LLP was associated with the Expo as its Knowledge Partner to EEPC India — an association that reflected our commitment to research-led consulting, strategic insight and industry intelligence.

As part of this association, ASM researched, developed and compiled a White Paper on the Pharmaceutical Machinery Manufacturing Industry in collaboration with EEPC India.

The objective was to create a structured industry perspective covering market developments, export opportunities, technology trends and the future direction of India's pharmaceutical machinery manufacturing ecosystem.

The White Paper Launch

★
A PROUD MOMENT FOR ASM

Officially launched by Shri Piyush Goyal

The White Paper was officially launched by Shri Piyush Goyal, Hon’ble Union Minister of Commerce & Industry, alongside Sandip Mukherjee, CEO, ASM StratConsult LLP.

For the ASM team, this was a particularly significant moment. It represented the culmination of extensive research and industry engagement behind the White Paper and highlighted the importance of bringing government, industry and knowledge institutions together around India's manufacturing ecosystem.

From Research to Industry Dialogue

The real value of an industry White Paper is not limited to its pages. It lies in the conversations and perspectives that it creates.

Throughout the Expo, the ASM team had the opportunity to engage with manufacturers, exporters, technology providers, industry leaders and other stakeholders. These interactions provided valuable perspectives on the priorities, challenges and ambitions shaping the sector.

01

Market Expansion

Identifying new markets and opportunities for business growth.

02

Export Opportunities

Strengthening India's participation in global pharmaceutical supply chains.

03

Technology & Automation

Understanding the technologies shaping future manufacturing competitiveness.

04

Global Competitiveness

Building capabilities for an increasingly competitive international marketplace.

Why Industry Intelligence Matters

India's pharmaceutical machinery ecosystem is operating in an increasingly dynamic global environment. Manufacturers are required to think beyond production capacity and consider technology, quality, global standards, market positioning, export readiness and strategic investment.

This makes industry intelligence increasingly important for businesses seeking to make informed strategic decisions.

  • Which international markets offer the strongest opportunities?
  • What technologies will influence future competitiveness?
  • How can Indian manufacturers strengthen their global presence?
  • What capabilities will businesses need for the next phase of growth?
  • How can companies translate industry trends into actionable strategy?

A Platform for India's Manufacturing Ambitions

Pharma MachTech & LabNext Expo 2026 demonstrated the increasingly interconnected nature of India's pharmaceutical, laboratory and healthcare manufacturing ecosystem.

The Expo created a platform where business, technology, policy and market opportunity could come together — enabling participants to exchange ideas, identify opportunities and build new relationships.

For ASM, participating as Knowledge Partner provided an opportunity to contribute to this dialogue from the perspective of research, consulting and strategic advisory.

Our Gratitude to EEPC India

ASM StratConsult LLP extends its sincere gratitude to EEPC India for entrusting us with the responsibility of serving as Knowledge Partner for Pharma MachTech & LabNext Expo 2026.

We are grateful for the opportunity to contribute through research, knowledge and strategic perspectives, and particularly proud to have developed the White Paper on the Pharmaceutical Machinery Manufacturing Industry as part of this association.

LOOKING AHEAD

Continuing the Conversation

The conclusion of the Expo marks not an ending, but the beginning of further conversations. ASM StratConsult LLP looks forward to continuing to work with businesses, manufacturers, exporters, policymakers and industry leaders to identify opportunities, address challenges and build sustainable growth.

Explore ASM StratConsult →
About ASM StratConsult LLP
ASM StratConsult LLP is a consulting firm focused on strategy, business growth, market intelligence, digital transformation and other strategic advisory requirements. Through research-led consulting and practical business understanding, ASM works with organisations to identify opportunities and develop strategies for sustainable growth.